The pharmaceutical industry is relentlessly driven by innovation, a process that relies heavily on a steady and dependable supply of high-quality chemical intermediates. These building blocks are fundamental to the synthesis of active pharmaceutical ingredients (APIs) that form the basis of life-saving and life-enhancing medications. Among the diverse array of chemical intermediates utilized, 3-Methylanisole, identified by its CAS number 100-84-5, stands out as a compound of significant interest. Its chemical structure and properties make it a valuable precursor in the development of various therapeutic agents. For research scientists and procurement specialists in the pharmaceutical sector, understanding the sourcing and application of 3-Methylanisole is crucial.
The Chemical Identity and Significance of 3-Methylanisole
3-Methylanisole, also known as 1-methoxy-3-methylbenzene or m-cresyl methyl ether, is an aromatic ether. Its molecular formula is C8H10O, and it is typically supplied as a transparent to slightly yellow liquid with a purity level often exceeding 99.00%. This specific molecular configuration provides reactive sites amenable to a variety of organic transformations essential in complex synthesis routes. The meta-positioning of the methoxy and methyl groups offers a unique structural element that medicinal chemists can leverage when designing new drug molecules or optimizing existing synthesis pathways.
3-Methylanisole in Pharmaceutical Synthesis
The journey from basic research to a marketable drug involves numerous intricate steps, and chemical intermediates like 3-Methylanisole play a pivotal role. Its applications in pharmaceutical synthesis include:
The purity of 3-Methylanisole is paramount in pharmaceutical applications. Impurities can lead to unwanted side reactions, affect the efficacy of the final drug, or introduce toxicity. Therefore, sourcing from suppliers who rigorously control quality and provide detailed analytical documentation is non-negotiable.
Reliable Sourcing of 3-Methylanisole from China Manufacturers
For pharmaceutical companies and contract research organizations (CROs), securing a consistent and high-quality supply of 3-Methylanisole (CAS 100-84-5) is a critical operational requirement. China has become a dominant force in the global chemical supply chain, offering a compelling option for sourcing such intermediates:
To find a reliable source, search terms like “buy 3-Methylanisole CAS 100-84-5 pharmaceutical intermediate,” “China manufacturer 3-Methylanisole,” or “pharmaceutical chemical supplier” are highly effective. Direct engagement with manufacturers allows for clarification of technical specifications, logistical arrangements, and pricing for bulk purchases.
In conclusion, 3-Methylanisole is a crucial chemical intermediate that underpins the development of numerous pharmaceuticals. By partnering with reputable China manufacturers, the pharmaceutical industry can ensure a stable, high-purity, and cost-effective supply of this vital compound, thereby accelerating drug discovery and development efforts and ultimately contributing to global health outcomes.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.